ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,3763
0,48%
Bitcoin
66.108,00
-0,80%
Brent Oil
81,955
-0,21%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Cesca Therapeutics Inc (KOOL)

  7. Cesca Therapeutics Inc (KOOL) Notícias

KOOL

Cesca Therapeutics (KOOL)

Cesca Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:KOOL
DataHoraFonteTítuloCódigoCompanhia
31/10/201907:30PR Newswire (US)Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic FocusNASDAQ:KOOLCesca Therapeutics Inc
24/10/201909:30PR Newswire (US)Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth ConferenceNASDAQ:KOOLCesca Therapeutics Inc
22/10/201911:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KOOLCesca Therapeutics Inc
22/10/201907:30PR Newswire (US)Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Serv...NASDAQ:KOOLCesca Therapeutics Inc
14/10/201909:30PR Newswire (US)Cesca Therapeutics To Present At The 2019 Bio Investor ForumNASDAQ:KOOLCesca Therapeutics Inc
02/10/201909:30PR Newswire (US)Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution FeeNASDAQ:KOOLCesca Therapeutics Inc
25/09/201911:25PR Newswire (US)ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing DevicesNASDAQ:KOOLCesca Therapeutics Inc
24/09/201915:35Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:KOOLCesca Therapeutics Inc
18/09/201919:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KOOLCesca Therapeutics Inc
12/09/201918:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KOOLCesca Therapeutics Inc
09/09/201909:30PR Newswire (US)Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® ProductsNASDAQ:KOOLCesca Therapeutics Inc
03/09/201909:30PR Newswire (US)Cesca Therapeutics To Present At The H.C. Wainwright 21st Annual Global Investment ConferenceNASDAQ:KOOLCesca Therapeutics Inc
13/08/201917:35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KOOLCesca Therapeutics Inc
13/08/201917:05PR Newswire (US)Cesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:KOOLCesca Therapeutics Inc
06/08/201909:30PR Newswire (US)Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On Aug...NASDAQ:KOOLCesca Therapeutics Inc
23/07/201909:30PR Newswire (US)America's Largest Cord Blood Bank, CBR®, Upgrading to ThermoGenesis' AXP® II SystemNASDAQ:KOOLCesca Therapeutics Inc
11/07/201917:35Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:KOOLCesca Therapeutics Inc
26/06/201909:30PR Newswire (US)Cesca Therapeutics Regains Nasdaq Listing ComplianceNASDAQ:KOOLCesca Therapeutics Inc
25/06/201909:30PR Newswire (US)Cordlife to Use the ThermoGenesis AXP® II System for Rapid Processing of Cord Blood Units in IndiaNASDAQ:KOOLCesca Therapeutics Inc
18/06/201909:30PR Newswire (US)ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood ProcessingNASDAQ:KOOLCesca Therapeutics Inc
05/06/201909:30PR Newswire (US)ThermoGenesis to Participate in The Orthobiologic Institute's 10th Annual PRP & Regenerative Medicine SymposiumNASDAQ:KOOLCesca Therapeutics Inc
04/06/201913:00PR Newswire (US)Cesca Therapeutics Announces 1-for-10 Reverse Split Of Common StockNASDAQ:KOOLCesca Therapeutics Inc
31/05/201907:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KOOLCesca Therapeutics Inc
16/05/201907:04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:KOOLCesca Therapeutics Inc
14/05/201917:05PR Newswire (US)Cesca Therapeutics Announces First Quarter 2019 Financial Results And Provides Corporate UpdateNASDAQ:KOOLCesca Therapeutics Inc
13/05/201916:35Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:KOOLCesca Therapeutics Inc
07/05/201909:30PR Newswire (US)Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2019 and Host a Conference Call on May...NASDAQ:KOOLCesca Therapeutics Inc
30/04/201916:44Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KOOLCesca Therapeutics Inc
22/04/201907:03Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:KOOLCesca Therapeutics Inc
17/04/201909:00PR Newswire (US)ThermoGenesis Releases its Enhanced X-MINI® CD3 Selection Kit for the Research MarketNASDAQ:KOOLCesca Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:KOOL

Seu Histórico Recente

BOV
HBOR3
HELBOR ON
BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados